Damora Therapeutics logo

Damora Therapeutics

GLTO | NASDAQ
Chart Builder DCF Calculator
$21.58
-$0.75 (-3.36%)
At close: Jun 4, 2026, 12:02 PM ET
-3.36%

Rating

Updated: Sep 30, 2026
22.5
+1.0 pts
Fundamentals Weak
Market Sentiment Neutral
Moat None

Key Statistics

Market Data

Market Cap $34.47M
1D Range
21.58 23.54
52W Range
2.01 38.33

Valuation (TTM)

PE -0.17
PB 0.07
EV/EBITDA 1.90

Valuation (NTM)

Forward PE N/A
Forward PEG -0.05
Price Target $35.25
Loading financial charts...

Profile

Damora Therapeutics, Inc., a biopharmaceutical company, develops therapies for the treatment of hematologic disorders in Denmark and North America. The company’s lead product includes DMR-001, a inves...

Sector Healthcare
Employees 7
IPO Date Oct 28, 2020
Fiscal Year January - December

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
1
Consensus
Buy
Price Target
$42.50
Upside
+96.94%
Buy (1)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.